GSE137702
Gene expression (RNA-Seq) in pediatric high-grade glioma cell lines treated with selinexor and vehicle
Cultured pediatric high-grade glioma cell lines (SU-DIPG-IV, HSJD-DIPG-007, HSJD-GBM-001,BT 245 (RRID:CVCL_IP13)) were treated with selinexor (Karyopharm Therapeutics) at 5xIC50 for 16 hours or vehicle (0.1% DMSO) followed by bulk RNA-Seq Overall design: Examination of the effects on gene expression of selinexor treatment of cultured pediatric brain tumor cell lines